Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

NCT03272425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: lesinurad/allopurinol 200/300 FDC tablets
DRUG: lesinurad 200 mg
DRUG: allopurinol 300 mg

Sponsor

Ardea Biosciences, Inc.